Developing: Second Ebola Patient Arrives In Atlanta

first_img Legal Advocate Discusses Medical Abuse At Shut Down Georgia ICE Facility The second U.S. patient infected with the deadly Ebola virus has arrived at a special isolation unit at Emory University Hospital in Atlanta for treatment.WABE reporter Michell Eloy talks with host Denis O’Hayer about the latest developments with the two U.S. Ebola patients, now both receiving treatment at Emory University Hospital.5:03North Carolina-missionary Nancy Writebol, 59, arrived via ambulance at Emory University Hospital just before 1 p.m. Tuesday, after being flown overnight from Liberia in a special medical evacuation plane.She arrived three days after fellow aid worker Dr. Kent Brantly, 33, and now joins him in the isolation unit that’s been set up in partnership with the Atlanta-based Centers for Disease Control and Prevention.While Brantly was able to walk out of the ambulance that transported him Saturday, the same was not true of Writebol, who was carried into the hospital on a stretcher and covered completely in a special protective suit.Bruce Johnson, the president of relief organization SIM USA, for which Writebol worked, said while Writebol is still “extremely weak,” her condition is improving. He said she was able to walk, with assistance, onto the airplane in Liberia.“She’s showing signs of progress and is moving in the right direction,” said Johnson. “And Nancy had yogurt before she got on the airplane,” an indication her appetite is returning. WABE’s Michell Eloy gives an update on the condition of Nancy Writebol.2:30Johnson said while he hasn’t seen yet seen Writebol, he’d spoken with her husband and fellow missionary, David.David told the SIM chief he’s optimistic about his wife’s recovery.“A week ago, [David] said, we were thinking about possible funeral arrangement. Yet we kept our faith. Now we have a real reason to be hopeful,” Johnson said.Johnson said the CDC is still investigating how Writebol and fellow missionary Dr. Kent Brantly contracted the deadly virus. Both had been working in Liberia, one of the three countries where the virus has been confirmed as part of a joint effort between relief groups Samaritan’s Purse and SIM USA.Johnson said CDC officials remain on the ground and are working to determine where the initial point of contact happened, though he insisted both followed and exceeded protocols established by their respective organizations and the CDC.He said Writebol worked in more of an administrative capacity and did not have direct contact with the patients, though she may have aided those who did have direct contact in spraying down hazmat suits.  SIM USA president Bruce Johnson on the decision to send Brantly back first, Johnson says it was made by the two patients and their attending physicians. 0:20In the meantime, both patients have been given an experimental drug, confirmed by the CDC and the National Institutes of Health as ZMapp. Not much is known about the drug – even the means by which it’s administered.What is known is that the drug is developed by San Diego-based company Mapp Biopharmaceuticals, and has never before been used on humans. Johnson said the drug was made available to the two patients in the middle of last week, and the decision to administer was made by the patients and their families, not the relief organization. SIM USA president Bruce Johnson says those working for the mission put their lives on the line.0:13CDC and NIH yesterday declined to elaborate on ZMapp’s treatment procedures. Mapp Biopharaceuticals did not return calls for comment.Up until now, there’s be no known cure for Ebola, though several are under development, including ZMapp. This is part of  WABE’s ongoing coverage of the Ebola virus and patients receiving treatment in Atlanta. For Whom The Bell Rings 5:03 | Play story Add to My ListIn My List Related Stories Share ‘It’s Fractured’: Georgia Lt. Gov. Geoff Duncan On Healing Republican Partylast_img read more